Publications by authors named "Lijin Duo"
Objective: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) target the reabsorption of sodium and glucose in the kidney proximal tubules to reduce blood sugar levels. However, clinical randomized controlled trials on SGLT2i have yielded inconsistent results, necessitating further research into their efficacy and safety for specific cardiac and renal diseases.
Methods: "Sodium in urine" was selected as a downstream biomarker of SGLT2i.
Background: Idiopathic membranous nephropathy (IMN) is a type of nephrotic syndrome and the leading cause of chronic kidney disease. As far as we know, no predictive model for assessing the prognosis of IMN is currently available. This study aims to establish a nomogram to predict remission probability in patients with IMN and assists clinicians to make treatment decisions.
View Article and Find Full Text PDFClinical predictive model to estimate probability of remission in patients with lupus nephritis.
Int Immunopharmacol
September 2022
Background: Lupus nephritis (LN) is a major organ complication and cause of morbidity and mortality in patients with systemic lupus erythematosus. This study aims to provide the clinician with a quantitative tool for the prediction of the individual remission probability of LN and obtain new insights for improved clinical management in LN treatment.
Methods: A total of 301 patients with renal biopsy-proven LN were recruited and randomly divided into model construction and validation group.
Clinical predictive model for the 1-year remission probability of IgA vasculitis nephritis.
Int Immunopharmacol
December 2021
Purpose: Early remission of Immunoglobulin A vasculitis nephritis (IgAVN) substantially affects its prognosis. In this work, a multivariate model to predict the 1-year remission probability of patients with IgAVN was developed on the basis of clinical laboratory data.
Methods: Data of 187 patients with IgAVN confirmed by renal biopsy were retrospectively assessed.